drugset / Trial / NCT00427505

Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam

NCT00427505

Phase 1 Completed 22 enrolled Novartis
Non-randomizedCrossoverOpen-labelTreatment

Summary

This is a study to investigate the pharmacokinetics of deferasirox

Timeline

Start
2006-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Deferasirox Unknown

Indications

No indication recorded.